Department of Health and Human Services September 17, 2008 – Federal Register Recent Federal Regulation Documents

Medical Devices; Medical Device Reporting; Baseline Reports; Confirmation of Effective Date
Document Number: E8-21756
Type: Rule
Date: 2008-09-17
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is confirming the effective date of October 27, 2008, for the final rule that appeared in the Federal Register of June 13, 2008 (73 FR 33692). The direct final rule amends the Medical Device Reporting regulation by removing the requirement for baseline reports. This document confirms the effective date of the direct final rule.
Part C Early Intervention Services Grant
Document Number: E8-21754
Type: Notice
Date: 2008-09-17
Agency: Department of Health and Human Services, Health Resources and Services Administration
The Health Resources and Services Administration (HRSA) will be providing temporary critical HIV medical care and treatment services through GLH Magnolia Medical Clinic to avoid a disruption of HIV clinical care to clients in Bolivar, Sunflower and Washington counties in Mississippi.
Maternal and Child Health Services; Universal Newborn Hearing Screening and Intervention Program
Document Number: E8-21753
Type: Notice
Date: 2008-09-17
Agency: Department of Health and Human Services, Health Resources and Services Administration
The National Center for Hearing Assessment and Management (NCHAM) at Utah State University is the national resource center for the Universal Newborn Hearing Screening and Intervention Program. Funds will be used to provide technical assistance and training for physiologic hearing screening services in Early Head Start and Head Start programs in 17 States with plans to expand to 3 additional States.
Proposed Data Collections Submitted for Public Comment and Recommendations
Document Number: E8-21690
Type: Notice
Date: 2008-09-17
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meetings
Document Number: E8-21631
Type: Notice
Date: 2008-09-17
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
Document Number: E8-21630
Type: Notice
Date: 2008-09-17
Agency: Department of Health and Human Services, National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meetings
Document Number: E8-21626
Type: Notice
Date: 2008-09-17
Agency: Department of Health and Human Services, National Institutes of Health
Oral Dosage Form New Animal Drugs; Sulfadiazine/Pyrimethamine Suspension
Document Number: E8-21625
Type: Rule
Date: 2008-09-17
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Animal Health Pharmaceuticals, LLC. The supplemental NADA provides for a revised human food safety warning on labeling for an oral suspension of sulfadiazine and pyrimethamine used for the treatment of equine protozoal myeloencephalitis (EPM).
Agency Information Collection Activities; Proposed Collection; Comment Request; Food Safety Survey
Document Number: E8-21624
Type: Notice
Date: 2008-09-17
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed reinstatement of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on a voluntary consumer survey about food safety.
Beverages; Bottled Water
Document Number: E8-21619
Type: Proposed Rule
Date: 2008-09-17
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is proposing to amend its bottled water regulations to require that source water, which is currently subject to weekly microbiological testing, be tested specifically for total coliform as is done for finished bottled water products. Further, FDA is proposing that if any coliform organisms are detected in source water or finished bottled water products, bottled water manufacturers would be required to test for the bacterium Escherichia coli (E. coli), an indicator of fecal contamination. FDA also is proposing to amend the adulteration provision of the bottled water standard to reflect the possibility of adulteration caused by the presence of filth. Bottled water containing E. coli would be considered adulterated, and source water containing E. coli would not be considered to be of a safe, sanitary quality and would be prohibited from use in the production of bottled water. In addition, this rule would require bottlers to rectify or eliminate the source of E. coli contamination in source water and keep records of such actions. Existing regulatory provisions would require bottled water manufacturers to keep records of new testing required by this rule. FDA tentatively concludes that this proposed rule, if finalized, will ensure that FDA's standards for the minimum quality of bottled water, as affected by fecal contamination, will be no less protective of the public health than those set by the Environmental Protection Agency (EPA) for public drinking water.
Agency Information Collection Activities; Proposed Collection; Comment Request; Voluntary Cosmetic Registration Program
Document Number: E8-21617
Type: Notice
Date: 2008-09-17
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the collection of information associated with the Voluntary Cosmetic Registration Program.
Noncompetitive Successor Award
Document Number: E8-21614
Type: Notice
Date: 2008-09-17
Agency: Department of Health and Human Services, Office of Refugee Resettlement, Refugee Resettlement Office, Children and Families Administration
In FY 2006, ORR awarded a competitive Services for Survivors of Torture grant to the Center for Multicultural Human Services (CMHS) in Falls Church, Virginia. The original project period was from September 30, 2006 through September 29, 2009. CMHS served as fiscal sponsor and legal entity of the approved project. As of March 31, 2008, CMHS ceased operations. CMHS has requested permission for Northern Virginia Family Service to assume the grant. Northern Virginia has agreed to this request. The effect of this deviation request is to transfer the grant from the initial grantee to a new grantee with the scope and operations of the grant remaining unchanged.
National Institute of General Medical Sciences; Amended Notice of Meeting
Document Number: E8-21524
Type: Notice
Date: 2008-09-17
Agency: Department of Health and Human Services, National Institutes of Health
National Center for Research Resources; Notice of Closed Meeting
Document Number: E8-21363
Type: Notice
Date: 2008-09-17
Agency: Department of Health and Human Services, National Institutes of Health
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.